Previous Close
$5.45
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$4.1 million USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
Nasdaq
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary global...
Community
- 0 posts discussing
0
Watchers
0
Visitors